Primary care physicians' decisions to initiate or switch anticoagulant therapy for atrial fibrillation are influenced by personal experience, patient risk-stratification, medication cost, and clinical support services.
Primary care physicians face multiple interrelated barriers, including cost, lack of experience, and limited clinical support, when deciding to initiate or switch anticoagulant therapy for patients with atrial fibrillation.
BACKGROUND: Oral anticoagulant therapy use in patients with atrial fibrillation (AF) remains suboptimal in Singapore, despite the availability of both warfarin and non-vitamin K antagonist oral anticoagulants (NOACs). Primary care physicians' (PCP) decision-making to initiate and select appropriate anticoagulant medication is pivotal in reducing complications among patients with AF. This study explored the factors influencing PCPs' decision-making in anticoagulant initiation and anticoagulant switch for patients with non-valvular AF. METHOD: The study design is qualitative research based on the theoretical framework of the Generalist Wheel of Knowledge, Understanding and Inquiry. In-depth interviews or focus group discussions were conducted with 27 PCPs in general practice in urban Singapore. The audio-recordings were transcribed and coded to identify themes, which are framed according to the "clinician", "patient", "medical condition and treatment" and "healthcare system and policy" domains. RESULTS: Personal training and experience with anticoagulant therapy; understanding patient risk-stratification; AF detection during clinical practice; medication cost; clinical support services for anticoagulation monitoring and constraints in existing care model influenced PCPs in their anticoagulant prescription. PCPs preferred to seek guidance from cardiologists in managing patients with newly diagnosed AF and attempted to engage their patients in decision-making regarding anticoagulant therapy. Some PCPs perceived sub-specialized primary care clinics focusing on AF co-management with cardiologists as an ideal setting for initiation and maintenance of anticoagulant therapy. CONCLUSIONS: PCPs are influenced by multiple interrelated factors while making decisions on anticoagulant initiation and anticoagulant switch for patients with AF. Their proposed care model to address the barriers awaits feasibility and acceptance assessment in future research.
Chaterji et al. (Tue,) conducted a other in Non-valvular atrial fibrillation (prescribing behavior) (n=27). Factors influencing anticoagulant prescribing was evaluated on Factors influencing PCPs' decision-making in anticoagulant initiation and switch. Primary care physicians' decisions to initiate or switch anticoagulant therapy for atrial fibrillation are influenced by personal experience, patient risk-stratification, medication cost, and clinical support services.